Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients
Not Applicable
Completed
- Conditions
- Migraine Disorders
- Registration Number
- NCT03435185
- Lead Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
- Brief Summary
The investigators aimed to evaluate the efficacy of greater occipital nerve and supraorbital nerve blockade with local anesthetics for the preventive treatment of migraine without aura.
- Detailed Description
A mixture of 1 ml 2% lidocaine and 0.9% 1 ml saline was injected bilaterally to GON and SON in the blockade patients. Placebo patients received 2 ml 0.9% saline in the same way. Patients were blinded to kind of injection.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 103
Inclusion Criteria
- Lack of benefits 1 year from preventive treatment or intolerance to their treatments.
- 18 ≥ years old
- Migraine without aura for more than 1 year, minimum of two or more migraine attacks per month.
Exclusion Criteria
- Patients with any chronic illness, medication overuse headache, a history of cranial and cervical surgery
- Allergies to local anesthetics
- Hemorrhagic diathesis
- Alcohol or drug abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change of Frequency of Headache Patients were followed up from baseline to 2 months after first injection. Number of headache days in a month. Scores from both months were averaged. Minimum=0 Maximum=30. Lower scores mean a better outcome.
Change of Severity of Headache Patients were followed up for 2 months from baseline after first injection. Mean visual analog scale (VAS) scores. Scores from both months were avareged. Minimum=0 Maximum=10. Lower scores mean a better outcome
- Secondary Outcome Measures
Name Time Method